Suppr超能文献

使用美国食品药品监督管理局(FDA)修订后的行业指导文件:独立主要标准,评估多用途隐形眼镜护理液的抗菌效果比较

Comparative antimicrobial efficacy of multi-purpose lens care solutions using the FDA's revised guidance document for industry: stand-alone primary criteria.

作者信息

Lever A M, Miller M J

机构信息

Bausch & Lomb Incorporated, Global Vision Care, Rochester, NY 14609, USA.

出版信息

CLAO J. 1999 Jan;25(1):52-6.

Abstract

PURPOSE

We evaluated six single-bottle, multi-purpose lens care solutions and a two component lens care system for disinfection efficacy according to the stand-alone primary criteria within the recently published U.S. Food and Drug Administration (FDA) Guidelines.

METHODS

One-tenth mL of 1 x 10(8) colony forming units (CFU)/mL of bacterial and fungal challenge organisms was added to each test solution. Following a specified period (e.g., each manufacturer's labeled minimum disinfection time), aliquots of inoculated test solution were neutralized and plated on validated recovery media. After incubation the number of viable microorganisms were enumerated and mean log reductions determined.

RESULTS

ReNu and ReNu MultiPlus met the FDA's acceptance criteria for stand-alone disinfectants against all challenge organisms: Staphylococcus aureus, Serratia marcescens, Pseudomonas aeruginosa, Candida albicans, and Fusarium solani. Opti-Free Express failed to meet the FDA's stand-alone disinfectant acceptance criteria for S. aureus, S. marcescens and C. albicans and Opti-Free Express with Opti-Free Supraclens failed to meet the acceptance criteria for either S. aureus and C. albicans. Opti-One failed to meet the FDA's stand-alone disinfectant acceptance criteria for C. albicans and F. solani. Both Complete and Solo-Care failed to meet the FDA's acceptance criteria for C. albicans.

CONCLUSIONS

This evaluation provides a direct comparison of antimicrobial activity (based on stand-alone criteria) for commercially available multi-purpose lens care solutions at their labeled minimum disinfection times. The results of this study should be considered when selecting appropriate lens care systems for patients.

摘要

目的

根据美国食品药品监督管理局(FDA)最近发布的指南中的独立主要标准,我们评估了六种单瓶多用途隐形眼镜护理液和一种双组分隐形眼镜护理系统的消毒效果。

方法

向每种测试溶液中加入0.1 mL浓度为1×10⁸菌落形成单位(CFU)/mL的细菌和真菌挑战微生物。在规定时间后(例如,每个制造商标明的最短消毒时间),取接种后的测试溶液等分试样进行中和,并接种到经过验证的复苏培养基上。培养后,计算存活微生物的数量并确定平均对数减少量。

结果

润明(ReNu)和润明多功能护理液(ReNu MultiPlus)符合FDA对所有挑战微生物(金黄色葡萄球菌、粘质沙雷氏菌、铜绿假单胞菌、白色念珠菌和茄病镰刀菌)的独立消毒剂接受标准。傲滴恒润(Opti-Free Express)不符合FDA对金黄色葡萄球菌、粘质沙雷氏菌和白色念珠菌的独立消毒剂接受标准,而傲滴恒润与傲滴超净护理液(Opti-Free Supraclens)组合不符合对金黄色葡萄球菌和白色念珠菌的接受标准。傲滴全护理液(Opti-One)不符合FDA对白色念珠菌和茄病镰刀菌的独立消毒剂接受标准。全能护理液(Complete)和索罗护理液(Solo-Care)均不符合FDA对白色念珠菌的接受标准。

结论

本评估提供了市售多用途隐形眼镜护理液在其标明的最短消毒时间下抗菌活性(基于独立标准)的直接比较。在为患者选择合适的隐形眼镜护理系统时,应考虑本研究结果。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验